Vivitrol 380 MG vial-diluents
Ended Awarded Last action
- Contract number
- SPE2DR26FM22L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,751
Award facts
- Contract value 100% obligated
- $9,750.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,750.83 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. Vivitrol (naltrexone) is a medication used in the treatment of opioid use disorder and alcohol dependence, reflecting the company's extensive portfolio of specialized medications across multiple therapeutic domains. The delivery order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, PA. The company's track record with the DLA demonstrates its capability to fulfill federal medical supply requirements through open competitive procurement, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FM22L?
SPE2DR26FM22L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FM22L worth?
The government has obligated $9,751 on SPE2DR26FM22L.
Is contract SPE2DR26FM22L an order under another contract?
Yes. SPE2DR26FM22L is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM22L competed?
The extent of competition for SPE2DR26FM22L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award